A carregar...

Molecular determinants for enzalutamide-induced transcription in prostate cancer

Enzalutamide, a second-generation androgen receptor (AR) antagonist, has demonstrated clinical benefit in men with prostate cancer. However, it only provides a temporary response and modest increase in survival, indicating a rapid evolution of resistance. Previous studies suggest that enzalutamide m...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Nucleic Acids Res
Main Authors: Yuan, Fuwen, Hankey, William, Wu, Dayong, Wang, Hongyan, Somarelli, Jason, Armstrong, Andrew J, Huang, Jiaoti, Chen, Zhong, Wang, Qianben
Formato: Artigo
Idioma:Inglês
Publicado em: Oxford University Press 2019
Assuntos:
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC6821169/
https://ncbi.nlm.nih.gov/pubmed/31501863
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1093/nar/gkz790
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!